Graves’ Disease 1835–2002. University of Sheffield Clinical Sciences Centre, Northern General Hospital, Sheffield, UK. Horm Res 2003;59(suppl 1):114–118. https://doi.org/10.1159/000067837 Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016. The Committee on
Phar-maceutical Affairs, Japanese Society for Pediatric Endocrinology, and the Pediatric Thyroid Dis-ease Committee, Japan Thyroid Association. Clin Pediatr Endocrinol. 2017; 26(2): 29–62.
Gunnar Kleinau; Sandra Mueller; Holger Jaeschke; Paul Grzesik; Susanne Neumann; Anne DiehlRalf PaschkeGerd Krause. Defining Structural and Functional Dimensions of theExtracellular Thyro-tropin Receptor Region*□SReceived for publication, December 10, 2010, and in revised form, March 1, 2011Published, JBC Paper in Press, April 27, 2011, DOI 10.1074/jbc.M110.211193.
Schroeder, Jr, M.D., Ph.D., and Lisa Cavacini, Ph.D. Structure and Function of Immunoglobulins.
doi: 10.1016/j.jaci.2009.09.046.
Sanders, Sara-Anne Roberts, Masayuki Maruyama. Understanding the thyrotropin receptor function—
structure relationship. Baillière's Clinical Endocrinology and Metabolism. Volume 11, Issue 3, October 1997, Pages 451-479. https://doi.org/10.1016/S0950-351X(97)80693-3.
Berg, John L Tymoczko, and Lubert Stryer. Biochemistry 5yh Edition, 2002.
Ginsberg, Diagnosis and management of Graves’ disease. CMAJ March 04, 2003 168 (5) 575-585;
https://www.cmaj.ca/content/cmaj/168/5/575.full.pdf
Blanco-Canosa Dr., Philip E. Dawson Dr. An Efficient Fmoc-SPPS Approach for the Generation of Thioe-ster Peptide Precursors for Use in Native Chemical Ligation† 20 August 2008 https://doi.org/10.1002/ange.200705471.
Stożek, A. Bossowski, K. Ziora, et al. Functional TSH receptor antibodies in children with autoimmune thyroid diseases. Autoimmunity, 51 (2018). (Cita nei Tsaba).
Hemminki Xinjun Lic Jan Sundquist, KristinaSundquist. The epidemiology of Graves' disease: Evidence of a genetic and an environmental contribution. Journal of Autoimmunity
Leepika Tuli and Habtom W. Ressom. LC–MS Based Detection of Differential Protein Expression. J Pro-teomics Bioinform. Author manuscript; available in PMC 2010 Oct 2.
Marius N. Stan and Rebecca S. Bahn. Risk Factors for Development or Deterioration of Graves' Ophthal-mopathy. Thyroid. 2010 Jul; 20(7): 777–783. doi: 10.1089/thy.2010.1634
Ząbczyńska, Kamila Kozłowska, and Ewa Pocheć. Glycosylation in the Thyroid Gland: Vital Aspects of Glycoprotein Function in Thyrocyte Physiology and Thyroid Disorders. Published online 2018 Sep 17. doi: 10.3390/ijms19092792.
Mehmet Gumustas, Sevinc Kurbanoglu, Bengi Uslu & Sibel A. Ozkan. UPLC versus HPLC on Drug Analy-sis: Advantageous, Applications and Their Validation Parameters.
MIcHIo NISHINO, SHIGEKI YABE, MASAMI MURAKAMI *, TsUGIYASU KANDA** AND IsAO KOBAYASHI Endocrine Journal 2001, 48 (2), 185-191. Detection of Antipituitary Anti bodies in Patients with Auto- immune Thyroid Disease
Stefan , Chengguo Wei ì , Angela Lombardi , Cheuk Wun Li , Erlinda S Concepcion , William B Inabnet , Randall Owen , Weijia Zhang , Yaron Tomer. Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity. Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12562-7. doi: 10.1073/pnas.1408821111. Epub 2014 Aug 13.
Miloš Žarković. The Role of Oxidative Stress on the Pathogenesis of Graves' Disease.
https://doi.org/10.1155/2012/302537
Misa Kim-Saijo, Takashi Akamizu, Koichi Ikuta, Yasuhiko Iida, Katsuyuki Ohmori, Kazumi Matsubara, Yoichi Matsuda, Misao Suzuki, Fumihiko Matsuda, Kazuwa Nakao. Generation of a transgenic an-imal model of hyperthyroid Graves' disease. https://doi.org/10.1002/eji.200324255.
Shahid; Muhammad A. Ashraf; Sandeep Sharma. Physiology, Thyroid Hormone, May 12, 2021.
Tuncel, Thyroid Stimulating Hormone Receptor. Published online 2017 Jan doi: 10.4274/2017.26.suppl.10 PMCID: PMC5283706
Naoko Ishido, Naoya Inoue, Mikio Watanabe, Yoh Hidaka, and Yoshinori . The Relationship Between Skewed X Chromosome Inactivation and the Prognosis of Graves' and Hashimoto's Diseases.
Thyroid. 2015 Feb 1; 25(2): 256–261. doi: 10.1089/thy.2014.0318
Genere , Marius N Stan. Current and Emerging Treatment Strategies for Graves' Orbitopathy. 2019 Feb;79(2):109-124. doi: 10.1007/s40265-018-1045-9.
Sears† and Chi-Huey Wong Department of Chemistry and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA Korta, Ewa Pochec; Glycosylation of thyroid-stimulating hormone receptor. Department of
Glycoconju-gate Biochemistry, Institute of Zoology and Biomedical Research, Jagiellonian University, Kra-kow, Poland
Ping Xu and Junmin Peng. Characterization of Polyubiquitin Chain Structure by Middle-down Mass Spectrometry. DOI: 10.1021/ac800016w. Published in final edited form as: J Proteomics Bioin-form. 2009 Oct 2; 2: 416–438. doi: 10.4172/jpb.1000102. Published online 2017 Apr 22.
doi: 10.1297/cpe.26.29
Behrendt, 1 ,* Peter White, 2 ,* and John Offe. Advances in Fmoc solid‐phase peptide synthesis.
doi: 10.1002/psc.2836.
Vita; Flavia Di Bari; Sarah Perelli ;Giovanni Capodicasa Salvatore Benvenga. Thyroid vascularization is an important ultrasonographic parameter in untreated Graves’ disease patients. Journal of Clin-ical & Translational Endocrinology Volume 15, March 2019, Pages 65-69.
https://doi.org/10.1016/j.jcte.2019.01.001
Kosugi , T Akamizu, O Takai, B S Prabhakar, L D Kohn. Winter 1991;1(4):321-30. The extracellular do-main of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies. doi: 10.1089/thy.1991.1.321.
Kosugi , T Ban, L D Kohn.Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor. 1993 Jan;7(1):114-30. doi:
10.1210/mend.7.1.8095322.
Morshed and T. F. Davies. Graves' Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies. Published online 2015 Sep 11. doi: 10.1055/s-0035-1559633.
Sargsyan, and Joshua M. Thurman, Molecular Imaging of Autoimmune Diseases and Inflammation.
PMID: 22554489
Dallas, S A Patibandla, N R Thotakura and B S Prabhakar Requirement of glycosylation of the human thyrotropin receptor ectodomain for its reactivity with autoantibodies in patients' sera. J Immu-nol 1997; 158:2798-2804; ; http://www.jimmuImmu-nol.org/content/158/6/2798
Almeling, DavidIlko, UlrikeHolzgrabe Charged aerosol detection in pharmaceutical analysis. 2012.
Akamizu, S Kosugi, L D Kohn, T Mori.Anti-thyrotropin (TSH) receptor antibody binding epitopes of TSH receptor: site-directed mutagenesis approach. PMID: 7515117
Smith, L. Hegedüs Graves’ disease. N Engl J Med, 375 (2016), pp. 1552-1565
Martin , Kristina M. Ilieva, Alessia Visconti, Michelle Beaumont 1, Steven J. Kiddle, Richard J. B. Dobson, Massimo Mangino, Ee Mun Lim, Marija Pezer, Claire J. Steves, Jordana T. Bell, Scott G. Wilson, Gordan Lauc, Mario Roederer, John P. Walsh, Tim D. Spector, and Sophia N. Karagiannis. Dysreg-ulated Antibody, Natural Killer Cell and Immune Mediator Profiles in Autoimmune Thyroid Dis-eases . Received: 12 February 2020; Accepted: 5 March 2020; Published: 9 March 2020 . doi:10.3390/cells9030665
Tuncel M, Aydin D, Yaman E, Tazebay UH, Güç D, Doğan AL, Taşbasan B, Uğur O. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. Cancer Biother Radio-pharm. 2007;22:443–449.
Vassart G, Kleinau G. TSH Receptor Mutations and Diseases. In: Endotext. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R et al, editors. South Dartmouth (MA); 2000.
Mohan and Robert Lind. A review of treatment options for Graves’ disease: why total thyroidectomy is a viable option in selected patients. Published online 2016 Sep 7. doi: 10.3402/jchimp.v6.32369.
Minich, C. Lenzner & N. G. Morgenthaler, MiLo GmbH, Bioassays GmbH and ‡Research. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor
Aso, Hiromi Matsuura, Atsushi Momobayashi, Yoshihisa Inukai, Naoto Sugawara, Tomoki Nakano, Ru-riko Yamamoto, Sadao Wakabayashi, Kohzo Takebayashi, Toshihiko Inukai. Profound Reduction in T-helper (Th) 1 lymphocytes in Peripheral Blood from Patients with Concurrent Type 1 Dia-betes and Graves' Disease. https://doi.org/10.1507/endocrj.K05-136
Nagayama, Hiroyuki Namba, Naokata Yokoyama, Shunichi Yamashita, and Masami Niwa. Role of Aspar-agine-linked Oligosaccharides in Protein Folding, Membrane Targeting, and Thyrotropin and Au-toantibody Binding of the Human Thyrotropin Receptor
Z. Huan M. A. RichardsY., Zha R., Francis R., LozanoJ. Ruan. Determination of inorganic pharmaceutical counterions using hydrophilic interaction chromatography coupled with a Corona® CAD detector. https://doi.org/10.1016/j.jpba.2009.06.039
Graves’ Disease Engl J Med 2016; 375:1552-1565 DOI: 10.1056/NEJMra1510030
Weetman, M.D., D.Sc. Graves' Disease. October 26, 2000 N Engl J Med 2000; 343:1236-1248 DOI:
10.1056/NEJM200010263431707. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor.
Rebecca S. Bahn, Graves’ Ophthalmopathy. N Engl J Med. 2010 Feb 25; 362(8): 726–738.
doi: 10.1056/NEJMra0905750
Volume 34, Issue 3, May 2010, Pages J307-J313. https://doi.org/10.1016/j.jaut.2009.11.019
McLachlan. Editor: Springer, 6.12.2012. (Citazione storia: pag.171). Graves’ Disease: Pathogenesis and Treatment, Basil Rapoport,
Vikas Chaudhary and Shahina Bano. Thyroid ultrasound. 2013 Mar-Apr; 17(2): 219–227.
Smith, M.D., and Laszlo Hegedüs, M.D., D.M.Sc. October 20, 2016; Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses Alessandro Antonelli
Eick,1 Tara J. Cepon-Robins,2 Maureen J. Devlin,3 Paul Kowal,4,5 Larry S. Sugiyama,1 and J. Josh Snod-grass. Development and validation of an ELISA for a biomarker of thyroid dysfunction, thyroid peroxidase autoantibodies (TPO-Ab), in dried blood spots. doi: 10.1186/s40101-020-00228-8